These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23604257)

  • 21. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
    Al-Saeedi M; Yassein T; Schultze D; Nickkholgh A; Bruns H; Zorn M; Hinz U; Ganten TM; Schemmer P
    Ann Transplant; 2016 Nov; 21():675-682. PubMed ID: 27799654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living Donor Versus Deceased Donor Liver Transplantation for HCC.
    Doğan SM; Kutlutürk K
    J Gastrointest Cancer; 2020 Dec; 51(4):1104-1106. PubMed ID: 32833221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in liver transplantation allocation systems.
    Schilsky ML; Moini M
    World J Gastroenterol; 2016 Mar; 22(10):2922-30. PubMed ID: 26973389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
    Mazur RD; Goldberg DS
    Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
    Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the MELD allocation after its implementation in liver transplantation.
    Benckert C; Quante M; Thelen A; Bartels M; Laudi S; Berg T; Kaisers U; Jonas S
    Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allocation of Donor Livers for Transplantation: A Contemporary Struggle.
    Gerber DA; Baliga P; Karp SJ
    JAMA Surg; 2018 Sep; 153(9):787-788. PubMed ID: 29926088
    [No Abstract]   [Full Text] [Related]  

  • 34. Model for end-stage liver disease score and MELD exceptions: 15 years later.
    Asrani SK; Kamath PS
    Hepatol Int; 2015 Jul; 9(3):346-54. PubMed ID: 26016462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
    Arjal R; Trotter JF
    Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation in Spain.
    de la Rosa G; Fondevila C; Navasa M
    Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directed solutions to address differences in access to liver transplantation.
    Ye F; Sheng Q; Feurer ID; Zhao Z; Fan R; Teng J; Ping J; Rega SA; Hanto DW; Shyr Y; Karp SJ
    Am J Transplant; 2018 Nov; 18(11):2670-2678. PubMed ID: 29689125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
    Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
    Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.